{"id":"W2093988174","doi":"10.1007/s10637-012-9886-7","title":"The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines","year":2012,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Abbott Laboratories","keywords":"PARP inhibitor; Irinotecan; Cancer research; Veliparib; Poly ADP ribose polymerase; Olaparib; Oxaliplatin; DNA damage; PARP1; Cancer; Synthetic lethality; DNA repair; Base excision repair; Colorectal cancer; Biology; Medicine; Polymerase; Internal medicine; DNA; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002610088,0.0006067051,0.0008596088,0.0008628988,0.0003239188,0.0004633026,0.0003431115,0.0003596437,0.003237163],"category_scores_gemma":[0.0002598166,0.0003156075,0.0005106649,0.0008052929,0.0002484216,0.0004547687,0.0003411091,0.00123916,0.0009210509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004657981,"about_ca_system_score_gemma":0.0005257229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00103133,"about_ca_topic_score_gemma":0.003436544,"domain_scores_codex":[0.9996867,0.00007315174,0.00002741148,0.00003411697,0.0001060756,0.00007259853],"domain_scores_gemma":[0.9998643,0.00003135483,0.00002415459,0.00002989406,0.00001772699,0.00003242896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003105567,0.001652648,0.001778958,0.0004581717,0.0001638877,0.0004472996,0.000126681,0.001746329,0.9250078,0.0005130648,0.004140048,0.06085971],"study_design_scores_gemma":[0.0005749463,0.009193888,0.02395681,0.0000325587,0.0001674019,0.001561226,0.0001516524,0.003582211,0.9369367,0.0002734379,0.02353451,0.00003460545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810562,0.005144343,0.001569833,0.0005898426,0.0002650453,0.0001396165,0.001173616,0.0004858258,0.009575675],"genre_scores_gemma":[0.9872859,0.003901149,0.001406003,0.0001384843,0.000057918,0.0000809189,0.001872428,0.0000417042,0.005215512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003237163,"threshold_uncertainty_score":0.01082939,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03616634036575846,"score_gpt":0.3192929074536835,"score_spread":0.2831265670879251,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}